Here are relevant reports on : protein-therapeutics-market

  • The Algae Protein Market is a burgeoning industry focused on the extraction and application of protein derived from algae. This market is fueled by the growing demand for sustainable, nutrient-rich, and plant-based protein sources. Algae protein, derived primarily from microalgae like spirulina and chlorella, offers high nutritional value and diverse applications in food, beverages, dietary supplements, and animal feed.

    • Published: March 2026
    • Price: $ 4950
    • TOC Available:
  • The market for Hemp Protein is estimated at USD xx Million in 2024; it is projected to grow at a CAGR of x% to reach USD xx Million by 2030. Key Market Players in this market are Axiom Foods, Inc. (USA), GFR Ingredients (Canada), Nutiva (USA), Manitoba Harvest (Canada), Hemp Oil Canada (Canada), North America Hemp & Grain Company (Canada), Hemp Food Australia (Australia), and Tilray Brands, Inc. (USA).

    • Published: March 2026
    • Price: $ 4950
    • TOC Available:
    • Published: March 2026
    • Price: $ 4950
    • TOC Available:
  • The global protein water market is growing fast due to increasing health consciousness, demand for convenient and functional beverages, and innovation in protein formulations. Consumers are now prioritizing fitness, hydration, and protein intake, and protein water has emerged as a convenient low-calorie, high-protein alternative to traditional protein shakes. The rising interest in plant-based proteins, clean-label products, and the addition of functional ingredients, such as vitamins, electrolytes, and collagen primarily drives this growth.

    • Published: March 2026
    • Price: $ 4950
    • TOC Available:
  • The plant-based protein processing equipment market is estimated at USD XX billion in 2024; it is projected to grow at a CAGR of XX% to reach USD XX billion by 2029. Key Market Players in this include ALFA LAVAL (Sweden), GEA Group Aktiengesellschaft (Germany), JBT (US), Buhler (Switzerland), Spx Flow (US), Tetra Pak International S.A. (Switzerland), Bepex International LLC (US), Pall Corporation (US), CRB (US), Coperion GmbH (Germany), OMVE Americas Inc. (Netherlands), Mepaco (US), Myande Group (China), Wafilin Systems (Netherlands), Hasokawa Micron B.V. (Netherlands).

    • Published: March 2026
    • Price: $ 4950
    • TOC Available:
  • The Fermented Plant-Based Protein Market is a rapidly growing sector catering to the increasing demand for sustainable, nutritious, and functional food solutions. This market focuses on the production of plant-derived proteins enhanced through fermentation to improve their nutritional value, functionality, and digestibility.

    • Published: March 2026
    • Price: $ 4950
    • TOC Available:
  • The market for duckweed protein is estimated at USD XX million in 2024; it is projected to grow at a CAGR of XX% to reach USD XX million by 2029. Key market players in this include Plantible Foods (US), Rubisco Foods (Netherlands), GreenOnyx (Israel), Parabel USA (US), Sustainable Planet (UK), Barentz (Netherlands), Hinoman (Israel), Lemnapro (Germany), SETA Organic Inc. (Canada), and The Green Farmer Co-operative Society Limited (Ireland).

    • Published: March 2026
    • Price: $ 4950
    • TOC Available:
  • The global oligonucleotide therapeutics market, valued at US$5.92 billion in 2024, stood at US$7.19 billion in 2025 and is projected to advance at a resilient CAGR of 19.7% from 2025 to 2030, culminating in a forecasted valuation of US$17.70 billion by the end of the period. The market is growing as more RNA-targeting therapies gain broader clinical acceptance. This increase is mainly driven by siRNAs and antisense candidates, supported by advances in delivery technologies like GalNAc conjugates and lipid nanoparticles.

    • Published: January 2026
    • Price: $ 4950
    • TOC Available:
  • The global digital therapeutics market, valued at US$4.4 billion in 2022, stood at US$6.1 billion in 2023 and is projected to advance at a resilient CAGR of 29.1% from 2023 to 2028, culminating in a forecasted valuation of US$21.9 billion by the end of the period. The rapid adoption of digital therapeutics is driven by the rising incidence of chronic diseases, surging investments from venture capital firms, and strategic partnerships between tech companies and healthcare providers.

    • Published: January 2024
    • Price: $ 4950
    • TOC Available:
  • The global medical automation market over the forecast period of 2015 to 2020. The market is expected to reach USD 55.03 Billion by 2020, at CAGR of 9.5% from 2015 to 2020. Continuous technological advancements in automation solutions, increasing government financial support for medical automation, rising labour costs, and growing need for reproducibility and accuracy are key factors fuelling the growth of the medical automation market. Increasing demand for automation in laboratories and pharmacies and high potential for early detection and treatment of diseases due to automation are some other prime factors offering growth opportunities for players in the medical automation market. However, high cost of automation is one of the key restraints for this market.

    • Published: February 2016
    • Price: $ 4950
    • TOC Available:

Records 21 to 30 of 50

DMCA.com Protection Status